ALGS Financial Statements

Balance sheet, income statement, cash flow, and dividends for Aligos Therapeutics Inc (ALGS).


$142.94M Market Cap.

As of 03/10/2025 5:00 PM ET (MRY) • Disclaimer

ALGS Market Cap. (MRY)


ALGS Shares Outstanding (MRY)


ALGS Assets (MRY)


Total Assets

$70.09M

Total Liabilities

$99.07M

Total Investments

$19.94M

ALGS Income (MRY)


Revenue

$3.94M

Net Income

-$131.21M

Operating Expense

$93.10M

ALGS Cash Flow (MRY)


CF Operations

-$80.74M

CF Investing

-$18.28M

CF Financing

$355.00K

ALGS Dividends (MRY)


Period

Dividends

Yield %

Growth %

Payout Ratio

Coverage Ratio

2024

$0

0%

0%

0%

-

2023

$0

0%

0%

0%

-

2022

$0

0%

0%

0%

-

2021

$0

0%

0%

0%

-

2020

$0

0%

-

0%

-

ALGS Balance Sheet (MRY)


Metric

2024

2023

2022

2021

Total Assets

$70,094,000 (-53.74%)

$151,527,000 (3.30%)

$146,693,000 (-37.68%)

$235,369,000 (-11.28%)

Assets Current

$62,141,000 (-55.95%)

$141,084,000 (5.65%)

$133,545,000 (-34.67%)

$204,424,000 (-18.24%)

Assets Non-Current

$7,953,000 (-23.84%)

$10,443,000 (-20.57%)

$13,148,000 (-57.51%)

$30,945,000 (102.45%)

Goodwill & Intangible Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Shareholders Equity

-$28,973,000 (-131.47%)

$92,080,000 (-11.38%)

$103,900,000 (-43.76%)

$184,731,000 (-16.05%)

Property Plant & Equipment Net

$7,326,000 (-25.38%)

$9,818,000 (-21.54%)

$12,514,000 (-16.40%)

$14,969,000 (0.41%)

Cash & Equivalents

$37,107,000 (-72.67%)

$135,774,000 (66.67%)

$81,462,000 (-56.43%)

$186,980,000 (-15.37%)

Accumulated Other Comprehensive Income

$451,000 (-17.25%)

$545,000 (35.91%)

$401,000 (-11.28%)

$452,000 (340.43%)

Deferred Revenue

$151,000 (-88.46%)

$1,308,000 (-86.15%)

$9,443,000 (23.58%)

$7,641,000 (-36.33%)

Total Investments

$19,942,000 (0%)

$0 (0%)

$44,480,000 (133.76%)

$19,028,000 (-17.73%)

Investments Current

$19,942,000 (0%)

$0 (0%)

$44,480,000 (1035.27%)

$3,918,000 (-83.06%)

Investments Non-Current

$0 (0%)

$0 (0%)

$0 (0%)

$15,110,000 (0%)

Inventory

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Receivables

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Trade & Non-Trade Payables

$2,571,000 (2.15%)

$2,517,000 (-46.87%)

$4,737,000 (57.11%)

$3,015,000 (-8.99%)

Accumulated Retained Earnings (Deficit)

-$618,008,000 (-26.95%)

-$486,797,000 (-21.97%)

-$399,118,000 (-31.69%)

-$303,072,000 (-73.44%)

Tax Assets

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Tax Liabilities

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Total Debt

$8,375,000 (-24.81%)

$11,138,000 (-11.42%)

$12,574,000 (-13.01%)

$14,455,000 (11.13%)

Debt Current

$3,458,000 (6.76%)

$3,239,000 (3.05%)

$3,143,000 (8.12%)

$2,907,000 (16.00%)

Debt Non-Current

$4,917,000 (-37.75%)

$7,899,000 (-16.24%)

$9,431,000 (-18.33%)

$11,548,000 (9.97%)

Total Liabilities

$99,067,000 (66.65%)

$59,447,000 (38.92%)

$42,793,000 (-15.49%)

$50,638,000 (11.88%)

Liabilities Current

$21,737,000 (-9.07%)

$23,906,000 (-27.84%)

$33,129,000 (-14.96%)

$38,957,000 (28.68%)

Liabilities Non-Current

$77,330,000 (117.58%)

$35,541,000 (267.77%)

$9,664,000 (-17.27%)

$11,681,000 (-22.07%)

ALGS Income Statement (MRY)


Metric

2024

2023

2022

2021

Revenues

$3,945,000 (-74.60%)

$15,529,000 (11.66%)

$13,907,000 (219.04%)

$4,359,000 (0%)

Cost of Revenue

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Selling General & Administrative Expense

$22,830,000 (-25.43%)

$30,616,000 (15.93%)

$26,410,000 (-7.42%)

$28,527,000 (58.98%)

Research & Development Expense

$70,269,000 (-3.79%)

$73,040,000 (-14.15%)

$85,077,000 (-18.32%)

$104,153,000 (30.37%)

Operating Expenses

$93,099,000 (-10.18%)

$103,656,000 (-7.02%)

$111,487,000 (-15.97%)

$132,680,000 (35.62%)

Interest Expense

-$4,406,000 (-254.47%)

-$1,243,000 (24.21%)

-$1,640,000 (-1142.42%)

-$132,000 (-101.25%)

Income Tax Expense

$331,000 (-58.36%)

$795,000 (650.00%)

$106,000 (-25.87%)

$143,000 (-11.18%)

Net Loss Income from Discontinued Operations

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Consolidated Income

-$131,211,000 (-49.65%)

-$87,679,000 (8.71%)

-$96,046,000 (25.16%)

-$128,332,000 (-18.23%)

Net Income to Non-Controlling Interests

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income

-$131,211,000 (-49.65%)

-$87,679,000 (8.71%)

-$96,046,000 (25.16%)

-$128,332,000 (-18.23%)

Preferred Dividends Income Statement Impact

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Income Common Stock

-$131,211,000 (-49.65%)

-$87,679,000 (8.71%)

-$96,046,000 (25.16%)

-$128,332,000 (-18.23%)

Weighted Average Shares

$6,264,612 (-90.25%)

$64,260,588 (50.51%)

$42,695,227 (7.13%)

$39,855,403 (299.03%)

Weighted Average Shares Diluted

$6,264,612 (-90.25%)

$64,260,588 (50.51%)

$42,695,227 (7.13%)

$39,855,403 (299.03%)

Earning Before Interest & Taxes (EBIT)

-$135,286,000 (-53.51%)

-$88,127,000 (9.69%)

-$97,580,000 (23.96%)

-$128,321,000 (-31.16%)

Gross Profit

$3,945,000 (-74.60%)

$15,529,000 (11.66%)

$13,907,000 (219.04%)

$4,359,000 (0%)

Operating Income

-$89,154,000 (-1.17%)

-$88,127,000 (9.69%)

-$97,580,000 (23.96%)

-$128,321,000 (-31.16%)

ALGS Cash Flow Statement (MRY)


Metric

2024

2023

2022

2021

Net Cash Flow from Investing

-$18,279,000 (-140.64%)

$44,981,000 (271.08%)

-$26,293,000 (-970.05%)

$3,022,000 (-90.77%)

Net Cash Flow from Financing

$355,000 (-99.60%)

$88,328,000 (53758.54%)

$164,000 (-99.79%)

$78,677,000 (-59.10%)

Net Cash Flow from Operations

-$80,743,000 (-2.21%)

-$78,997,000 (0.49%)

-$79,389,000 (31.36%)

-$115,662,000 (-55.75%)

Net Cash Flow / Change in Cash & Cash Equivalents

-$98,667,000 (-281.67%)

$54,312,000 (151.47%)

-$105,518,000 (-210.69%)

-$33,963,000 (-122.52%)

Net Cash Flow - Business Acquisitions and Disposals

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Net Cash Flow - Investment Acquisitions and Disposals

-$18,149,000 (-140.33%)

$45,000,000 (277.51%)

-$25,350,000 (-747.68%)

$3,914,000 (-88.76%)

Capital Expenditure

-$130,000 (-584.21%)

-$19,000 (97.99%)

-$943,000 (-5.72%)

-$892,000 (56.78%)

Issuance (Repayment) of Debt Securities

-$83,000 (13.54%)

-$96,000 (-57.38%)

-$61,000 (22.78%)

-$79,000 (-36.21%)

Issuance (Purchase) of Equity Shares

$438,000 (-98.99%)

$43,444,000 (19208.44%)

$225,000 (-99.72%)

$79,631,000 (-48.89%)

Payment of Dividends & Other Cash Distributions

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Effect of Exchange Rate Changes on Cash

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Share Based Compensation

$8,452,000 (-33.20%)

$12,652,000 (-13.89%)

$14,693,000 (9.18%)

$13,457,000 (352.34%)

Depreciation Amortization & Accretion

$2,622,000 (-14.57%)

$3,069,000 (-16.49%)

$3,675,000 (-2.73%)

$3,778,000 (13.62%)

ALGS Financial Metrics (MRY)


Metric

2024

2023

2022

2021

Gross Margin

100.00% (0.00%)

100.00% (0.00%)

100.00% (0.00%)

100.00%

Profit Margin

-3326.00% (-489.09%)

-564.60% (18.25%)

-690.60% (76.54%)

-2944.10%

EBITDA Margin

-3362.80% (-513.99%)

-547.70% (18.88%)

-675.20% (76.37%)

-2857.10%

Return on Average Equity (ROAE)

-354.30% (-204.38%)

-116.40% (-56.24%)

-74.50% (-11.19%)

-67.00% (52.11%)

Return on Average Assets (ROAA)

-132.80% (-76.13%)

-75.40% (-38.10%)

-54.60% (-0.55%)

-54.30% (-3.04%)

Return on Sales (ROS)

-3429.30% (-504.28%)

-567.50% (19.12%)

-701.70% (76.16%)

-2943.80%

Return on Invested Capital (ROIC)

-262.90% (74.16%)

-1017.50% (-617.56%)

-141.80% (85.65%)

-988.40% (-425.47%)

Dividend Yield

0% (0%)

0% (0%)

0% (0%)

0% (0%)

Price to Earnings Ratio (P/E)

-1.9 (-289.96%)

-0.49 (-15.09%)

-0.42 (88.50%)

-3.69 (-44.89%)

Price to Sales Ratio (P/S)

63.27 (2202.22%)

2.75 (-6.05%)

2.92 (-97.30%)

108.53

Price to Book Ratio (P/B)

-4.93 (-1013.70%)

0.54 (37.40%)

0.39 (-85.65%)

2.74 (-42.84%)

Debt to Equity Ratio (D/E)

-3.42 (-629.26%)

0.65 (56.80%)

0.41 (50.36%)

0.27 (33.01%)

Earnings Per Share (EPS)

-20.94 (-1439.71%)

-1.36 (39.56%)

-2.25 (30.12%)

-3.22 (70.38%)

Sales Per Share (SPS)

0.63 (160.33%)

0.24 (-25.77%)

0.33 (199.08%)

0.11 (0%)

Free Cash Flow Per Share (FCFPS)

-12.91 (-949.51%)

-1.23 (34.64%)

-1.88 (35.64%)

-2.92 (61.74%)

Book Value Per Share (BVPS)

-4.63 (-422.75%)

1.43 (-41.13%)

2.43 (-47.49%)

4.63 (-78.96%)

Tangible Assets Book Value Per Share (TABVPS)

11.19 (374.51%)

2.36 (-31.37%)

3.44 (-41.82%)

5.91 (-77.77%)

Enterprise Value Over EBIT (EV/EBIT)

-1 (0%)

0 (0%)

0 (0%)

-2 (81.82%)

Enterprise Value Over EBITDA (EV/EBITDA)

-0.88 (-929.25%)

0.11 (-69.54%)

0.35 (115.60%)

-2.23 (79.63%)

Asset Turnover

0.04 (-70.15%)

0.13 (69.62%)

0.08 (338.89%)

0.02 (0%)

Current Ratio

2.86 (-51.56%)

5.9 (46.42%)

4.03 (-23.18%)

5.25 (-36.46%)

Dividends

$0 (0%)

$0 (0%)

$0 (0%)

$0 (0%)

Free Cash Flow (FCF)

-$80,873,000 (-2.35%)

-$79,016,000 (1.64%)

-$80,332,000 (31.08%)

-$116,554,000 (-52.70%)

Enterprise Value (EV)

$116,633,617 (1399.36%)

-$8,976,253 (72.54%)

-$32,688,021 (-111.76%)

$277,888,187 (-73.15%)

Earnings Before Tax (EBT)

-$130,880,000 (-50.64%)

-$86,884,000 (9.44%)

-$95,940,000 (25.16%)

-$128,189,000 (-18.28%)

Earnings Before Interest Taxes & Depreciation Amortization (EBITDA)

-$132,664,000 (-55.97%)

-$85,058,000 (9.42%)

-$93,905,000 (24.60%)

-$124,543,000 (-31.78%)

Invested Capital

$19,625,000 (557.45%)

$2,985,000 (-93.32%)

$44,676,000 (87.03%)

$23,887,000 (-11.83%)

Working Capital

$40,404,000 (-65.52%)

$117,178,000 (16.69%)

$100,416,000 (-39.31%)

$165,467,000 (-24.70%)

Tangible Asset Value

$70,094,000 (-53.74%)

$151,527,000 (3.30%)

$146,693,000 (-37.68%)

$235,369,000 (-11.28%)

Market Capitalization

$142,941,617 (187.29%)

$49,754,747 (21.95%)

$40,798,979 (-91.93%)

$505,854,187 (-52.00%)

Average Equity

$37,037,000 (-50.83%)

$75,321,500 (-41.59%)

$128,945,000 (-32.65%)

$191,461,500 (146.81%)

Average Assets

$98,808,250 (-15.05%)

$116,311,750 (-33.89%)

$175,938,750 (-25.52%)

$236,213,250 (14.72%)

Invested Capital Average

$51,465,750 (494.24%)

$8,660,750 (-87.41%)

$68,800,250 (429.93%)

$12,983,000 (-75.04%)

Shares

3,587,892 (-95.21%)

74,931,848 (75.01%)

42,815,593 (0.47%)

42,616,191 (11.80%)